NIH-funded research R01 grant

Using genomics to improve care for cryptococcal meningitis in people with HIV

Official title: Genomic Research Capacity Building for Cryptococcal Meningitis

Funded at Virginia Polytechnic Inst and St Univ · NIH-11381310 · Data updated 2026-11-12

This project builds lab and training capacity to use genomic and immune testing to help adults with HIV who get cryptococcal meningitis.

More Meningitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVirginia Polytechnic Inst and St Univ
NIH-funded
Lab location1 site (Blacksburg, United States)
Project startSeptember 1, 2020
Project endNovember 30, 2030
Funding year2026
Award (this year)$122,478
NIH project number3R01NS118538-06S2
Project IDNIH-11381310 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with advanced HIV and confirmed cryptococcal meningitis treated at participating hospitals who can consent to sample collection and follow-up.

Less likely to help

Children under 21, people without cryptococcal meningitis, or those not treated at participating sites are unlikely to receive direct benefit from this project.

What this research studies

From a patient perspective, the team is strengthening labs and training doctors and scientists in Uganda so they can do genomic and immune-system studies on cryptococcal meningitis. They will collect clinical samples from people with HIV and meningitis at partner hospitals and analyze fungal genes and host immune responses. The work links local clinical care with lab-based genomics to look for targets for better diagnostics and treatments. The project is a long-term partnership between Virginia Tech and Ugandan institutions to turn lab findings into practices that could be used in hospitals.

Why it matters

Potential benefit: If successful, this could lead to new tests or treatment strategies that reduce death and long-term brain injury from cryptococcal meningitis in people with HIV.

How similar studies have gone: The team and others have made important discoveries about cryptococcal biology and immune responses, but translating those findings into widely used treatments remains limited.

Where this research is happening

  • Virginia Polytechnic Inst and St Univ
    Blacksburg, United States
    Active

Researchers

  • Principal investigator: Nielsen, Kirsten — Virginia Polytechnic Inst and St Univ
  • Study coordinator: Nielsen, Kirsten

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.